Home
About
Overview
Sharing Data
ORCID
Help
History (24)
Epigenome-Microbiome crosstalk: A potential new paradigm influencing neonatal susceptibility to disease.
Manipulating the microbiome to improve the efficacy of immunotherapy.
Association of synovial inflammation and inflammatory mediators with glenohumeral rotator cuff pathology.
MDMA enhances pleasantness of affective touch.
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes.
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes.
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes. Circulation. 2021 02 09; 143(6):540-552.
View in:
PubMed
subject areas
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Double-Blind Method
Female
Humans
Male
Naphthyridines
Renal Insufficiency, Chronic